Thorsten Waloschek: 3D-Bioprinted Placentas Could Predict and Prevent Preeclampsia
Thorsten Waloschek, CEO at NeoPredics AG, shared a post on LinkedIn:
“Scientists in Sydney have 3D-bioprinted miniature placentas – a breakthrough that could transform how we understand pregnancy complications like preeclampsia.
Until now, studying the early placenta has been almost impossible. By the time a baby is born, the organ looks very different from its first-trimester state, and animal models don’t capture the unique biology of humans. Bioprinting changes that. Researchers can now grow organoids that closely mimic early placental tissue, expose them to stressors linked to preeclampsia, and even test potential therapies.
It is still early days, but this feels like a leap toward a future where complications in pregnancy could be predicted, prevented, or treated before they put lives at risk. Advances like this remind us how much innovation in bioengineering can ripple far beyond the lab, reshaping the health of generations to come.”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 12, 2026, 17:18Emad Sedeek: New Technologies in the IVF Laboratory
-
Sep 12, 2026, 17:16Rahul Singh Parmar: IVF Lab QC – Culture Medium vs. EmbryoGlue
-
Sep 12, 2026, 17:14The Countdown to the FIGO Montréal 2027 Call for Submissions Is On
-
Sep 12, 2026, 17:11Kevin Pho: For Anyone Who Prescribes Testosterone or Runs a Fertility Practice
-
Sep 12, 2026, 17:08Diane Horsfield: Building Individually Owned Fertility Insurance at Flora Fertility
-
Sep 12, 2026, 17:06Carmen Mair: 5 Things in Fertility that Can’t Be Improved
-
Sep 12, 2026, 17:04Aumatma Simmons: 2 Methods for Accurate Fertility Tracking
-
Sep 12, 2026, 17:02Sometimes, Getting Another Perspective Can Bring a Little More Clarity – Viera Fertility
-
Sep 12, 2026, 17:00Applications Are Open for Cloudnine’s 1-Year Fellowship in Reproductive Medicine for OB/GYNs